Original paper
A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)
Volume: 99, Issue: 3, Pages: 754 - 762
Published: Nov 18, 2021
Abstract
Objectives We investigated the clinical efficacy of a paclitaxel‐coated balloon (PCB) with a novel matrix coating and reduced drug concentration in comparison with a widely used PCB with iopromide excipient. Methods We prospectively enrolled patients with restenosis in drug‐eluting stents. All patients were treated with a novel low‐dose PCB with citrate‐based excipient (Agent PCB). Angiographic follow‐up was scheduled at 6–8 months. Outcomes...
Paper Details
Title
A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)
Published Date
Nov 18, 2021
Volume
99
Issue
3
Pages
754 - 762